You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.
Technology Review reports some researchers are trying homemade SARS-CoV-2 vaccines on themselves.
In more than a dozen new papers, ENCODE researchers reported on analyses of the human and mouse genomes, using new data types and additional tissues.
The partners will use ReviveMed's AI-driven platform to better understand mechanisms of immunotherapy response and resistance in cancer patients.
The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.
The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.
In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.
The Massachusetts Institute of Technology has ended its journal subscription contract negotiations with Elsevier.
A comparative genomics and machine-learning analysis spanning almost 1,000 viral genomes pointed to two proteins that appear to be altered in SARS-CoV-2 and MERS-CoV.
In Nature this week: genome-wide association study of 42 diseases among Japanese population, transfer RNA modifications, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.
Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.
According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.
In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.